ePrints

Neurocognitive impairment in drug-free patients with major depressive disorder

Lookup NU author(s): Dr Richard Porter, Dr Peter GallagherORCiD, Jill Thompson, Professor Allan Young

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Background: Although neurocognitive impairment has been widely reported in major depressive disorder (MDD), confounding factors, such as the effects of psychotropic medication, have rarely been controlled for. Aims: To examine neurocognitive function in medication-free patients with MDD and healthy controls. Method: Forty-four patients meeting DSM-IV criteria for MDD, all psychotropic-medication-free for at least 6 weeks, and 44 demographically matched, healthy comparison subjects completed a comprehensive neurocognitive battery. Results: Patients with depression were impaired significantly in a range of cognitive domains, including attention and executive function and visuospatial learning and memory, compared with controls. Motor and psychomotor functions were intact. Severity of depression correlated with learning and memory performance, but not executive function. Conclusions: Pronounced neurocognitive impairment was found in this sample of young adult out-patients with MDD. This is not attributable to the confounding effects of psychotropic medication and could therefore provide an objective marker of brain dysfunction in depression.

Publication metadata

Author(s): Porter RJ, Gallagher P, Thompson JM, Young AH

Publication type: Article

Publication status: Published

Journal: British Journal of Psychiatry

Year: 2003

Volume: 182

Pages: 214-220

ISSN (print): 0007-1250

ISSN (electronic): 1472-1465

Publisher: Royal College of Psychiatrists

URL: http://dx.doi.org/10.1192/bjp.182.3.214

DOI: 10.1192/bjp.182.3.214

PubMed id: 12611784

Altmetrics

Share